A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy

Table 1 Characterization of the copolymers

Copolymer	Composition ratio^a	Mn^a (Da)	Mn^b (Da)	PDI^b
PEG-b-PLLZ	113:15	9315	9166	1.08
PEG-b-PLL	113:15	6874	6953	1.07
PEG-b-P(LL-g-TK)	113:15:13	10,178	10,273	1.13
P(L-TK-DOX)	113:15:13:6	13,568	13,947	1.16

ISSN: 1477-3155